FDA Orange Book · active-ingredient family
Furosemide
Furosemide: 26 brands, 47 generics; first approved Feb 26, 1982; generic available.
Generic availableHas discontinued products
Generic status & protection
Generic available: 47 ANDA applications approved.
Earliest patent expiry
Brands (NDA)
26
Generics (ANDA)
47
Listed patents
17
Next patent expiry
Apr 03, 2034
in 7 yr 7 mo
Brand (NDA) products
Originator applications
- SQ INNOVATIONNDA 2172942025
Approved strengths under this FDA application. Strength Dosage form Route Status TE 80MG/2.67ML (30MG/ML) SOLUTION SUBCUTANEOUS Rx — - SCPHARMACEUTICALSNDA 20998820222 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 80MG/10ML (8MG/ML) SOLUTION SUBCUTANEOUS Rx — 80MG/ML (80MG/ML) SOLUTION SUBCUTANEOUS Rx — - FUROSEMIDERLDAM REGENTNDA 0185791983
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Discontinued — - LASIXRLDSANOFI AVENTIS USNDA 016363—
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Discontinued — - LASIXRLDSANOFI AVENTIS USNDA 017688—
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML SOLUTION ORAL Discontinued — - LASIXRLDVALIDUS PHARMSNDA 016273—3 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 40MG TABLET ORAL Discontinued — 20MG TABLET ORAL Discontinued — 80MG TABLET ORAL Discontinued — - FUROSEMIDEABRAXIS PHARMNDA 0190361984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Discontinued — - FUROSEMIDEEPIC PHARMA LLCNDA 0187501984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 40MG TABLET ORAL Discontinued — - FUROSEMIDESUPERPHARMNDA 01837019842 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 40MG TABLET ORAL Discontinued — 20MG TABLET ORAL Discontinued — - FUROSEMIDEFRESENIUS KABI USANDA 0189021984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Rx AP - FUROSEMIDEINTL MEDICATIONNDA 01875319842 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 20MG TABLET ORAL Discontinued — 40MG TABLET ORAL Discontinued — - FUROSEMIDECHARTWELL RXNDA 01841319832 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 20MG TABLET ORAL Discontinued — 40MG TABLET ORAL Discontinued — - FUROSEMIDESUN PHARM INDS INCNDA 0187901983
Approved strengths under this FDA application. Strength Dosage form Route Status TE 40MG TABLET ORAL Discontinued — - FUROSEMIDEHIKMANDA 01882319832 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 20MG TABLET ORAL Rx AB 40MG TABLET ORAL Rx AB - FUROSEMIDEKALAPHARMNDA 01886819832 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 20MG TABLET ORAL Discontinued — 40MG TABLET ORAL Discontinued — - FUROSEMIDEWARNER CHILCOTTNDA 01841919833 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 20MG TABLET ORAL Discontinued — 40MG TABLET ORAL Discontinued — 80MG TABLET ORAL Discontinued — - FUROSEMIDEABRAXIS PHARMNDA 0185071982
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Discontinued — - FUROSEMIDEESJAY PHARMANDA 01841519823 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 20MG TABLET ORAL Rx AB 40MG TABLET ORAL Rx AB 80MG TABLET ORAL Rx AB - FUROSEMIDEWYETH AYERSTNDA 0186701982
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Discontinued — - FUROSEMIDEHOSPIRANDA 0186671982
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Rx AP - FUROSEMIDEWATSON LABSNDA 01836919822 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 20MG TABLET ORAL Discontinued — 40MG TABLET ORAL Discontinued — - FUROSEMIDEWARNER CHILCOTTNDA 0184201982
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Discontinued — - FUROSEMIDEHIKMANDA 018267—
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Rx AP - FUROSEMIDEINTL MEDICATIONNDA 018025—
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Discontinued — - FUROSEMIDEEPIC PHARMA LLCNDA 018569—3 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 40MG TABLET ORAL Rx AB 20MG TABLET ORAL Rx AB 80MG TABLET ORAL Rx AB - FUROSEMIDEPHARMOBEDIENTNDA 018487—2 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 20MG TABLET ORAL Discontinued — 40MG TABLET ORAL Discontinued —
Generic (ANDA) products (47)
Abbreviated applications
- FUROSEMIDEMICRO LABSANDA 2181882026
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Rx AP - FUROSEMIDEAUROBINDO PHARMA LTDANDA 21883120253 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 20MG TABLET ORAL Rx AB 40MG TABLET ORAL Rx AB 80MG TABLET ORAL Rx AB - FUROSEMIDEASPIROANDA 2175572024
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Rx AP - FUROSEMIDESABA ILAC SANAYIVEANDA 2158562024
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Rx AP - FUROSEMIDEMANKIND PHARMAANDA 2168602022
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Rx AP - FUROSEMIDEGRAVITI PHARMSANDA 21662920223 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 20MG TABLET ORAL Rx AB 40MG TABLET ORAL Rx AB 80MG TABLET ORAL Rx AB - FUROSEMIDEMEITHEALANDA 2128032022
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Rx AP - FUROSEMIDESAGENTANDA 2147662021
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Rx AP - FUROSEMIDEAREVA PHARMSANDA 2084352020
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Rx AP - FUROSEMIDEGLANDANDA 2139022020
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Rx AP - FUROSEMIDEEUGIA PHARMAANDA 2121742019
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Rx AP - FUROSEMIDEAMNEAL PHARMS COANDA 2075522016
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Discontinued — - FUROSEMIDEAVET LIFESCIENCESANDA 2034282014
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Rx AP - FUROSEMIDESUN PHARM INDS INCANDA 09125820143 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 20MG TABLET ORAL Discontinued — 40MG TABLET ORAL Discontinued — 80MG TABLET ORAL Discontinued — - FUROSEMIDERSBAXTER HLTHCARE CORPANDA 2027472014
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Rx AP - FUROSEMIDEAPOTEXANDA 0779412007
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Rx AP - FUROSEMIDEIPCA LABS LTDANDA 07801020063 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 20MG TABLET ORAL Rx AB 40MG TABLET ORAL Rx AB 80MG TABLET ORAL Rx AB - FUROSEMIDELEADINGANDA 07729320053 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 20MG TABLET ORAL Rx AB 40MG TABLET ORAL Rx AB 80MG TABLET ORAL Rx AB - FUROSEMIDEPRINSTON INCANDA 07679620043 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 20MG TABLET ORAL Rx AB 40MG TABLET ORAL Rx AB 80MG TABLET ORAL Rx AB - FUROSEMIDEHOSPIRAANDA 0752411999
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Rx AP - FUROSEMIDEHOSPIRAANDA 0743371994
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Discontinued — - FUROSEMIDEMARSAM PHARMS LLCANDA 0740171994
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Discontinued — - FUROSEMIDEHOSPIRAANDA 0720801991
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Discontinued — - FUROSEMIDEHIKMAANDA 0714391990
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Discontinued — - FUROSEMIDEANI PHARMSANDA 0715941988
Approved strengths under this FDA application. Strength Dosage form Route Status TE 80MG TABLET ORAL Discontinued — - FUROSEMIDESUN PHARM INDUSTRIESANDA 0701001988
Approved strengths under this FDA application. Strength Dosage form Route Status TE 80MG TABLET ORAL Discontinued — - FUROSEMIDEPHARMOBEDIENT CNSLTGANDA 0706551987
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML SOLUTION ORAL Discontinued — - FUROSEMIDEHOSPIRAANDA 0705781987
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Discontinued — - FUROSEMIDERSHIKMAANDA 0704341987
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML SOLUTION ORAL Rx — - FUROSEMIDERSHIKMAANDA 0704331987
Approved strengths under this FDA application. Strength Dosage form Route Status TE 40MG/5ML SOLUTION ORAL Rx — - FUROSEMIDEWATSON LABSANDA 0706041987
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Discontinued — - FUROSEMIDEANI PHARMSANDA 0713791987
Approved strengths under this FDA application. Strength Dosage form Route Status TE 20MG TABLET ORAL Discontinued — - FUROSEMIDEACCORD HLTHCAREANDA 0700171986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Rx AP - FUROSEMIDEPHARMOBEDIENTANDA 0700821986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 80MG TABLET ORAL Discontinued — - FUROSEMIDEWATSON LABSANDA 0700191986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Discontinued — - FUROSEMIDEANI PHARMSANDA 0704131986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 40MG TABLET ORAL Discontinued — - FUROSEMIDEWATSON LABSANDA 0704121986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 20MG TABLET ORAL Discontinued — - FUROSEMIDESMITH AND NEPHEWANDA 0700231986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Discontinued — - FUROSEMIDESMITH AND NEPHEWANDA 0700781986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Discontinued — - FUROSEMIDEHIKMAANDA 0700861986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 80MG TABLET ORAL Rx AB - FUROSEMIDEWATSON LABS TEVAANDA 0705281986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 80MG TABLET ORAL Discontinued — - FUROSEMIDEWATSON LABSANDA 0704501985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 40MG TABLET ORAL Discontinued — - FUROSEMIDEWATSON LABS TEVAANDA 0704491985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 20MG TABLET ORAL Discontinued — - FUROSEMIDESUN PHARM INDUSTRIESANDA 0700431985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 20MG TABLET ORAL Discontinued — - FUROSEMIDEASTRAZENECAANDA 0700141985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Discontinued — - FUROSEMIDEIGI LABS INCANDA 0700951985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Discontinued — - FUROSEMIDEIGI LABS INCANDA 0700961985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10MG/ML INJECTABLE INJECTION Discontinued —
Patent & exclusivity timeline
Protection horizon
Patent expiryExclusivity endToday
Listed patents
Orange Book patent file
| Patent | Expires | In | Type |
|---|---|---|---|
| 11433044 | in 7 yr 7 mo | U-3462 | |
| 9884039 | in 7 yr 7 mo | U-3462 | |
| 12370168 | in 7 yr 7 mo | ProductU-3462 | |
| 10272064 | in 7 yr 7 mo | Product | |
| 11246851 | in 13 yr 5 mo | ProductU-4576 | |
| 12318363 | in 13 yr 5 mo | Product | |
| 12491197 | in 13 yr 6 mo | ProductU-4588 | |
| 12491196 | in 13 yr 6 mo | ProductU-4588 | |
| 12491195 | in 13 yr 6 mo | ProductU-4588 | |
| 12491194 | in 13 yr 6 mo | ProductU-4588 | |
| 12491193 | in 13 yr 6 mo | ProductU-4588 | |
| 12048709 | in 13 yr 6 mo | ProductU-4588 | |
| 11998555 | in 13 yr 6 mo | ProductU-4589 | |
| 11559535 | in 13 yr 6 mo | Product | |
| 11571434 | in 13 yr 6 mo | Product | |
| 11497755 | in 13 yr 6 mo | Product | |
| 12403120 | in 15 yr 5 mo | ProductU-4576 |
Approval history
FDA approval span
First approval
45 yr 3 mo ago
Most recent approval
3 mo ago
Approvals span 1982–2026 across 73 FDA applications.
Brand (NDA) 2636%
Generic (ANDA) 4764%
Furosemide: frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.

Go beyond the database.
Try Assyro Intelligence for your regulatory research. Ready to discuss your team’s workflow? Book a demo.
